Joseph Chao, MD

Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA

Dr. Chao earned his medical degree at the University of Illinois at Chicago, and while there developed his passion for oncologic research working in the laboratory of Dr. Ronald Hoffman. He continued his post-graduate training in internal medicine at Harbor-UCLA Medical Center, and medical oncology and hematology fellowships at City of Hope Comprehensive Cancer Center and Harbor-UCLA. He subsequently was recruited on faculty at City of Hope where he currently serves as an Assistant Clinical Professor in the Department of Medical Oncology and Therapeutics Research with a clinical focus on treating patients with gastrointestinal malignancies. His primary research interests lie in developing novel therapeutics for gastroesophageal cancers where he has led investigator-initiated studies and actively participated in multi-institutional trials. His research has been recognized by the NIH Paul Calabresi Career Development Award in Clinical Oncology for ongoing projects in immunotherapeutics and the development of microRNA biomarkers. Dr. Chao’s expertise has helped shape national treatment guidelines where he serves on the National Comprehensive Cancer Network (NCCN) panels for Gastric and Esophageal Cancers and is the current academic co-chair for Via Oncology Pathways in gastroesophageal malignancies.